Malignant schwannoma of the upper mediastinum originating from the vagus nerve by Shoji, Fumihiro et al.
BioMed  Central
Page 1 of 4
(page number not for citation purposes)
World Journal of Surgical Oncology
Open Access Case report
Malignant schwannoma of the upper mediastinum originating from 
the vagus nerve
Fumihiro Shoji*1, Riichiroh Maruyama1, Tatsuro Okamoto1, 
Hiroshi Wataya1, Kenichi Nishiyama2 and Yukito Ichinose1
Address: 1Department of Thoracic Oncology, Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka 811-1395, Japan and 2Department of 
Pathology, Kyushu Cancer Center, 3-1-1, Notame, Minami-ku, Fukuoka 811-1395, Japan
Email: Fumihiro Shoji* - shoji-f@koseikan.jp; Riichiroh Maruyama - rmaruyama@nk-cc.go.jp; Tatsuro Okamoto - tokamoto@nk-cc.go.jp; 
Hiroshi Wataya - hwataya@nk-cc.go.jp; Kenichi Nishiyama - kennishi@nk-cc.go.jp; Yukito Ichinose - yichinos@nk-cc.go.jp
* Corresponding author    
Abstract
Background: Malignant schwannoma of the upper mediastinum originating from the vagus nerve
is extremely rare.
Case presentation: A 46-year-old female was admitted for a left cervical mass which was
associated with both hoarseness and Horner's syndrome. Chest computed tomography showed a
mass extending from the left upper mediastinum to the left supraclavicular area. A fine needle
aspiration cytological examination suggested primary lung cancer stage IIIB large cell carcinoma.
After administering induction chemo-radiotherapy, a complete surgical resection was performed.
The tumor was found to involve both the left vagus nerve and the left sympathetic nerve.
Histological examination of the resected specimen revealed the tumor to be malignant
schwannoma.
Conclusion: Despite incorrect preoperative diagnosis, the multimodality treatment administered
in this case, including induction chemo-radiotherapy and surgery, proved to be effective.
Background
According to a collected series of 2399 cases of mediasti-
nal tumors reported in the literature [1], 496 cases
(20.7%) were of neurogenic tumors, and most of them
occurred in the posterior mediastinum. Neurogenic
tumors can be divided into two groups depending on
their origin: those that arise from the nerve sheath and
those that arise from nerve cells. The majority of the
tumors of nerve sheath origin in adults are either benign
schwannomas or neurofibromas, and they usually arise
from either an intercostal nerve or a sympathetic nerve.
Intrathoracic schwannoma originating from the vagus
nerve, is extremely rare.
Case presentation
A 46-year-old female with symptoms of hoarseness and
Horner's syndrome presented with a left cervical mass that
was diagnosed to be undifferentiated carcinoma based on
the findings of aspiration cytology (Figure 1). The
patient's chest computed tomography (CT) findings
showed a mass measuring 5.0 cm in size spreading from
the left upper mediastinum to the left supraclavicular
area, which pressed against both the trachea and
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esophagus and it seemed to involve the left common
carotid artery (Figure 2). Based on these findings, and
cytology findings a clinical diagnosis of stage IIIB
(T4N3M0) non-small cell lung cancer (NSCLC) originat-
ing from the apex of the left lung involving both the medi-
astinum and the supraclavicular lymph nodes was made
[2]. The patient received concurrent chemo-radiotherapy
(cisplatin 80 mg/m2 for days 8 and 36 + UFT 400 mg/m2,
both on days 1–14 and on days 29–42 plus radiotherapy,
2 Gy/day on days 1–20 for a total of 40 Gy) [3]. After this
treatment regimen, the tumor size decreased by 35.0%.
Thereafter, the patient underwent a surgical resection
though a median sternotomy with a combined resection
of the left clavicle. During the operation, an encapsulated
tumor was detected in the mediastinum. Although the
tumor was easily ablated from the left common carotid
artery, it involved both the left vagus and the sympathetic
nerves. As a result, both nerves had to be sacrificed in
order to achieve a complete resection of the tumor.
Grossly, the tumor was in continuity of the vagus nerve
was whitish in color and oval shaped measuring 5 × 3 cm
in diameter (Figure 3). Both cytological and histological
examinations revealed 1) Continuity between the vagus
nerve and tumor was seen, while the no continuity
between the tumor and the sympathetic nerve was found.
2) The findings of aspiration cytology of the tumor diag-
nosing it to be undifferentiated carcinoma before the
treatment included an atypical spindle cell. (Figure 1). 3)
The predominantly tumor consisted of necrotic tissue and
a few viable atypical spindle cells (Figure 4A) which were
positive for S-100 protein (Figure 4B). As a result, the
tumor was considered to arise from the left vagus nerve
while invading the left sympathetic ganglion, and was
therefore diagnosed it to be a malignant schwannoma. At
present, the patient has survived for about 2 years since
operation without any recurrence.
Discussion
Tumors of vagus nerve origin are observed in about 2% of
all neurogenic tumors of the mediastinum [4], however,
no instace of malignant schwannoma was reported in this
review. To our knowledge, only a few such cases have
been previously reported [5-7]. As a result, malignant
schwannoma originating from the vagus nerve is therefore
considered to be extremely rare.
Malignant peripheral nerve sheath tumors (MPNST)
including malignant schwannoma are the malignant
variants of schwannomas and neurofibromas. Although
the 5-year survival rates have been reported to be up to 75
% in MPNST's patients, MPNST often advance locally and
can also occasionally metastasize to the lung or other
organs [8]. Therefore, in addition to a complete surgical
resection, adjuvant therapy is usually advocated. How-
ever, in an adjuvant setting, the efficacy of chemotherapy
or radiotherapy appears to provide little additional bene-
fit [9,10]. We previously reported concurrent chemo-radi-
otherapy with UFT plus cisplatin as an induction
treatment followed by a surgical resection for patients
with marginally resectable stage IIIB NSCLC to be both a
feasible and promising treatment [3]. Since we preopera-
tively considered the disease to be marginally resectable
stage IIIB NSCLC, we performed concurrent induction
chemo-radiotherapy followed by surgery. As a result, this
Aspiration cytology of the tumor before treatment showing  scattered atypical spindle cells (arrows) (Giemsa staining,  high power view x400) Figure 1
Aspiration cytology of the tumor before treatment showing 
scattered atypical spindle cells (arrows) (Giemsa staining, 
high power view x400).
Chest CT showed a mass, measuring 5.0 cm in size in the  upper mediastinum Figure 2
Chest CT showed a mass, measuring 5.0 cm in size in the 
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Macroscopic findings of the tumor Figure 3
Macroscopic findings of the tumor. The tumor showing the continuity of the vagus nerve (arrow head) was whitish in color and 
oval shaped while measuring 5 × 3 cm in diameter.
Histological findings of the tumor Figure 4
Histological findings of the tumor. 4A) The tumor was found to consist of a few of viable atypical spindle cells with hyperchro-
matic nuclei (Hematoxilin-eosin staining x200) 4B). Tumor cells were positive for S-100 protein (immunohistochemical stain-
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multimodality treatment proved to be effective and the
patient is now doing well without any recurrence.
We initially misdiagnosed this patient's disease to be non-
small cell lung cancer. The reason for this was partly due
to the cytological findings which indicated undifferenti-
ated carcinoma. In general, an exact diagnosis cannot
always be made based on the findings of aspiration cytol-
ogy alone. The second reason for a misdiagnosis in this
case was due to the patient's symptoms which included
hoarseness and Horner's syndrome. Apical lung cancer
involving both the vagus and the sympathetic nerve is
occasionally observed. However, to the best of our knowl-
edge, the present case is considered to be the first case
demonstrating malignant schwannoma of the vagus nerve
involving the sympathetic nerve.
Conclusion
Malignant schwannoma of the upper mediastinum aris-
ing from the vagus nerve is rare. The multimodality treat-
ment administered in this case, including induction
chemo-radiotherapy and surgery, proved to be effective.
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